RS44004A - Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth - Google Patents
Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growthInfo
- Publication number
- RS44004A RS44004A YU44004A YUP44004A RS44004A RS 44004 A RS44004 A RS 44004A YU 44004 A YU44004 A YU 44004A YU P44004 A YUP44004 A YU P44004A RS 44004 A RS44004 A RS 44004A
- Authority
- RS
- Serbia
- Prior art keywords
- processes
- cell growth
- abnormal cell
- bicyclid
- derivatives
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title abstract 2
- 230000010261 cell growth Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Pronalazak se odnosi na postupke za dobijanje jedinjenja formule (1) i njegove farmaceutski prihvatljie soli, prolekove i solvate, gde su R1, R2, R4, R5, R11, m i p kao što je ovde definisano. Jedinjenja formule (1) su korisni u lečenju abnormalnog rasta ćelija kod sisara, administriranjem farmaceutskih preparata.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33464701P | 2001-11-30 | 2001-11-30 | |
| PCT/IB2002/004097 WO2003045939A1 (en) | 2001-11-30 | 2002-10-03 | Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS44004A true RS44004A (en) | 2006-10-27 |
Family
ID=23308141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU44004A RS44004A (en) | 2001-11-30 | 2002-10-03 | Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20030144506A1 (sr) |
| EP (1) | EP1448551B1 (sr) |
| JP (1) | JP4220388B2 (sr) |
| KR (1) | KR20040054813A (sr) |
| CN (1) | CN1639149A (sr) |
| AR (1) | AR037591A1 (sr) |
| AT (1) | ATE377009T1 (sr) |
| AU (1) | AU2002337428A1 (sr) |
| BR (1) | BR0214606A (sr) |
| CA (1) | CA2462149C (sr) |
| DE (1) | DE60223279T2 (sr) |
| DO (1) | DOP2002000519A (sr) |
| ES (1) | ES2295409T3 (sr) |
| GT (1) | GT200200245A (sr) |
| HN (1) | HN2002000334A (sr) |
| HU (1) | HUP0500117A3 (sr) |
| IL (1) | IL160971A0 (sr) |
| MX (1) | MXPA04005157A (sr) |
| PA (1) | PA8558601A1 (sr) |
| PE (1) | PE20030643A1 (sr) |
| PL (1) | PL370911A1 (sr) |
| RS (1) | RS44004A (sr) |
| RU (1) | RU2004116345A (sr) |
| SV (1) | SV2004001419A (sr) |
| TN (1) | TNSN02096A1 (sr) |
| TW (1) | TW200300691A (sr) |
| WO (1) | WO2003045939A1 (sr) |
| ZA (1) | ZA200402054B (sr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0317433A (pt) * | 2002-12-18 | 2005-11-16 | Pfizer Prod Inc | Derivados bicìclicos para o tratamento do crescimento celular anormal |
| JP2006512355A (ja) * | 2002-12-19 | 2006-04-13 | ファイザー・プロダクツ・インク | Ｅ−２−メトキシ−ｎ−（３−｛４−［３−メチル−４−（６−メチルピリジン−３−イルオキシ）−フェニルアミノ］−キナゾリン−６−イル｝−アリル）−アセトアミドの複合体、それらの製造方法および使用 |
| AU2004228460A1 (en) * | 2003-04-09 | 2004-10-21 | Pfizer Products Inc. | Processes for the preparation of N-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| CN1984660B (zh) * | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉 |
| US20050192298A1 (en) * | 2004-02-27 | 2005-09-01 | Pfizer Inc | Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide |
| UA85706C2 (en) * | 2004-05-06 | 2009-02-25 | Уорнер-Ламберт Компани Ллси | 4-phenylaminoquinazolin-6-yl amides |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
| EP1976686A4 (en) * | 2005-12-02 | 2011-12-28 | Paper Products Ltd | HOLOGRAPHIC SOFT TUBULAR LAMINATE FOR PACKAGING AND PROCESS FOR PRODUCING THE SAME |
| CN113382986A (zh) | 2018-09-25 | 2021-09-10 | 黑钻治疗公司 | 酪氨酸激酶抑制剂组合物、其制备方法和使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW321649B (sr) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| DE19501481A1 (de) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-Disubstituierte Chinazolinone |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| EE200200710A (et) * | 2000-06-22 | 2004-06-15 | Pfizer Products Inc. | Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks |
-
2002
- 2002-10-03 MX MXPA04005157A patent/MXPA04005157A/es active IP Right Grant
- 2002-10-03 CN CNA028208994A patent/CN1639149A/zh active Pending
- 2002-10-03 BR BR0214606-1A patent/BR0214606A/pt not_active IP Right Cessation
- 2002-10-03 IL IL16097102A patent/IL160971A0/xx unknown
- 2002-10-03 AT AT02772689T patent/ATE377009T1/de not_active IP Right Cessation
- 2002-10-03 ES ES02772689T patent/ES2295409T3/es not_active Expired - Lifetime
- 2002-10-03 JP JP2003547389A patent/JP4220388B2/ja not_active Expired - Fee Related
- 2002-10-03 HU HU0500117A patent/HUP0500117A3/hu unknown
- 2002-10-03 RS YU44004A patent/RS44004A/sr unknown
- 2002-10-03 PL PL02370911A patent/PL370911A1/xx unknown
- 2002-10-03 DE DE60223279T patent/DE60223279T2/de not_active Expired - Lifetime
- 2002-10-03 CA CA2462149A patent/CA2462149C/en not_active Expired - Fee Related
- 2002-10-03 RU RU2004116345/04A patent/RU2004116345A/ru not_active Application Discontinuation
- 2002-10-03 AU AU2002337428A patent/AU2002337428A1/en not_active Abandoned
- 2002-10-03 KR KR10-2004-7008290A patent/KR20040054813A/ko not_active Application Discontinuation
- 2002-10-03 EP EP02772689A patent/EP1448551B1/en not_active Expired - Lifetime
- 2002-10-03 WO PCT/IB2002/004097 patent/WO2003045939A1/en active IP Right Grant
- 2002-11-21 DO DO2002000519A patent/DOP2002000519A/es unknown
- 2002-11-25 PE PE2002001129A patent/PE20030643A1/es not_active Application Discontinuation
- 2002-11-25 TW TW091134197A patent/TW200300691A/zh unknown
- 2002-11-25 PA PA20028558601A patent/PA8558601A1/es unknown
- 2002-11-27 HN HN2002000334A patent/HN2002000334A/es unknown
- 2002-11-28 GT GT200200245A patent/GT200200245A/es unknown
- 2002-11-28 AR ARP020104590A patent/AR037591A1/es unknown
- 2002-11-29 SV SV2002001419A patent/SV2004001419A/es not_active Application Discontinuation
- 2002-11-29 TN TNTNSN02096A patent/TNSN02096A1/en unknown
- 2002-12-02 US US10/307,603 patent/US20030144506A1/en not_active Abandoned
-
2004
- 2004-03-15 ZA ZA200402054A patent/ZA200402054B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200200245A (es) | 2003-09-24 |
| ATE377009T1 (de) | 2007-11-15 |
| WO2003045939A1 (en) | 2003-06-05 |
| PA8558601A1 (es) | 2003-06-30 |
| EP1448551A1 (en) | 2004-08-25 |
| HUP0500117A2 (hu) | 2005-05-30 |
| AU2002337428A1 (en) | 2003-06-10 |
| JP2005515986A (ja) | 2005-06-02 |
| PL370911A1 (en) | 2005-05-30 |
| DE60223279T2 (de) | 2008-05-29 |
| MXPA04005157A (es) | 2004-08-11 |
| EP1448551B1 (en) | 2007-10-31 |
| IL160971A0 (en) | 2004-08-31 |
| HN2002000334A (es) | 2003-02-21 |
| CA2462149C (en) | 2010-06-22 |
| KR20040054813A (ko) | 2004-06-25 |
| US20030144506A1 (en) | 2003-07-31 |
| PE20030643A1 (es) | 2003-07-23 |
| AR037591A1 (es) | 2004-11-17 |
| HUP0500117A3 (en) | 2008-03-28 |
| BR0214606A (pt) | 2004-09-14 |
| RU2004116345A (ru) | 2005-03-27 |
| DOP2002000519A (es) | 2003-05-31 |
| TW200300691A (en) | 2003-06-16 |
| ZA200402054B (en) | 2005-05-23 |
| JP4220388B2 (ja) | 2009-02-04 |
| ES2295409T3 (es) | 2008-04-16 |
| CN1639149A (zh) | 2005-07-13 |
| SV2004001419A (es) | 2004-02-24 |
| TNSN02096A1 (en) | 2005-12-23 |
| DE60223279D1 (de) | 2007-12-13 |
| CA2462149A1 (en) | 2003-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU95102A (sh) | Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija | |
| MXPA05006420A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal. | |
| YU30702A (sh) | Novi derivati benzoimidazola, korisni agensi protiv proliferacije | |
| RS20050180A (en) | Novel benzoimidazole derivatives useful as antiproliferative agensts | |
| MY124390A (en) | Substituted bicyclic derivatives useful as anticancer agents | |
| GT199900139A (es) | Derivados de quinolin-2-ona ùtiles como agentes contra el càncer. | |
| ATE260263T1 (de) | Heteroaromatische bizyklische verbindungen mit antikrebswirkung | |
| AP2001002079A0 (en) | Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents. | |
| BG104998A (en) | Isothiazole derivatives useful as anticancer agents | |
| MXPA04000577A (es) | Derivados de dolastatina 10. | |
| WO2006067614A3 (en) | Heteroaromatic derivatives useful as anticancer agents | |
| MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
| AP2001002302A0 (en) | 13-Methyl erythromycin derivatives. | |
| RS44004A (en) | Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth | |
| DE69734678D1 (de) | 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung | |
| AP2002002494A0 (en) | Hygromycin derivatives. | |
| CA2352332A1 (en) | Hygromycin a derivatives | |
| MXPA02011966A (es) | Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios. | |
| AP2002002492A0 (en) | Hygromycin a prodrugs. |